Search

Your search keyword '"J Koizumi"' showing total 20 results

Search Constraints

Start Over You searched for: Author "J Koizumi" Remove constraint Author: "J Koizumi" Journal atherosclerosis Remove constraint Journal: atherosclerosis
20 results on '"J Koizumi"'

Search Results

2. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.

3. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

4. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.

5. Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia.

6. Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia.

7. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.

8. Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency.

9. Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia.

10. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.

12. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency.

13. Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia.

14. Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum.

15. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia.

16. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).

17. Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apheresis.

18. Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system.

19. Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia.

20. Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan.

Catalog

Books, media, physical & digital resources